a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLMNX | 26.56 | -0.07 | -0.26% |
Harding Loevner International Eq Inv | |||
FVCSX | 40.82 | -0.20 | -0.49% |
Fidelity Advisor Value Strategies C | |||
WEEIX | 12.27 | -0.08 | -0.65% |
TETON Westwood Equity I | |||
MIQBX | 13.89 | -0.11 | -0.79% |
Morgan Stanley Inst International Eq A | |||
ASCZX | 11.05 | -0.31 | -2.73% |
Alger Small Cap Growth Z |
A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with ADMA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then ADMA could also see price increases.
Ticker / NAME | Correlation To IMTX | 1D Price Change % | ||
---|---|---|---|---|
IMTX | 100% | -4.22% | ||
ADMA - IMTX | 38% Loosely correlated | -5.74% | ||
MRUS - IMTX | 33% Loosely correlated | -6.20% | ||
KRRO - IMTX | 33% Poorly correlated | -4.31% | ||
FULC - IMTX | 31% Poorly correlated | -9.49% | ||
SNPX - IMTX | 31% Poorly correlated | -8.05% | ||
More |